Abstract 1213: PDE10A as a novel target to suppress Wnt/β-catenin signaling and other oncogenic pathways in ovarian cancer
Rebecca Barber(University of South Alabama), Luciana Madeira da Silva(USA Mitchell Cancer Institute), Antonio Ward(USA Mitchell Cancer Institute), Alla Musiyenko(USA Mitchell Cancer Institute), Kevin J. Lee(University of Alabama at Birmingham), Ileana Aragon(University of South Alabama), Joel Andrews(USA Mitchell Cancer Institute), Elaine Gavin(USA Mitchell Cancer Institute), Gary A. Piazza(Auburn University), Wito Richter(University of South Alabama), Kristy Berry(USA Mitchell Cancer Institute), Jennifer Scalici(University of Virginia Health System), Xi Chen(First Affiliated Hospital of Xiamen University), Annelise Wilhite(USA Mitchell Cancer Institute), Steve McClellan(University of South Alabama), Adam B. Keeton(Washburn University)
Cited by 1
Related Papers
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
Ligand steric properties
|Coordination Chemistry Reviews|1993|210
Cardiac Troponin I Gene Knockout
|Circulation Research|1999|157
Frailty: An outcome predictor for elderly gynecologic oncology patients
|Gynecologic Oncology|2012|140
Tertian and Quartan Fevers: Temporal Regulation in Malarial Infection
|Journal of Biological Rhythms|2001|77